3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorderActive, not recruitingPhase 22026-10-01NCT04464980
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use DisorderChemically-Induced Disorders, Hemic and Lymphatic Diseases, Narcotic-Related Disorders, Neoplasms by Histologic Type, Opioid Use Disorder, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, opiate dependence, psychiatric disorder, substance-related disorderRecruitingPhase 22026-08-11NCT06651177
Project COMET: Massed Prolonged Exposure for PTSD and SUDChemically-Induced Disorders, Stress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorder, substance-related disorderRecruitingNot applicable2025-10-27NCT06968832